Guowang Cheng

515 total citations
18 papers, 389 citations indexed

About

Guowang Cheng is a scholar working on Physiology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Guowang Cheng has authored 18 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 5 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Guowang Cheng's work include Alzheimer's disease research and treatments (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Extracellular vesicles in disease (3 papers). Guowang Cheng is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Extracellular vesicles in disease (3 papers). Guowang Cheng collaborates with scholars based in China, Macao and Singapore. Guowang Cheng's co-authors include Tongkai Chen, Guang‐Tao Yu, Zhenfeng Wu, Xiaojia Chen, Yuyue Zhao, Rui Ma, Yujing Liu, Zhou Lan, Lang Rao and Limin Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Chemical Engineering Journal.

In The Last Decade

Guowang Cheng

16 papers receiving 383 citations

Peers

Guowang Cheng

BIOMA

IMMUN

Dwaipayan Bhattacharya India

Kunhua Wang China

Sujuan Sun China

Chengcheng Sang China

Jinxu Cao China

Vincenzo Mangini Italy

Sha Xiong China

Shinya Yokomizo United States

Alice Gaudin United States

Dwaipayan Bhattacharya India

Guowang Cheng

191 ×1.2

186 ×1.8

105 ×1.2

169 ×2.3

BIOMA

30 ×0.6

IMMUN

Citations per year, relative to Guowang Cheng Guowang Cheng (= 1×) peers Dwaipayan Bhattacharya

Countries citing papers authored by Guowang Cheng

Since Specialization

Citations

This map shows the geographic impact of Guowang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowang Cheng more than expected).

Fields of papers citing papers by Guowang Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guowang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowang Cheng. The network helps show where Guowang Cheng may publish in the future.

Co-authorship network of co-authors of Guowang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guowang Cheng. A scholar is included among the top collaborators of Guowang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guowang Cheng. Guowang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yin, Xianyong, Jinmei Qiu, Guowang Cheng, et al.. (2025). Biomimetic nanodelivery system with simultaneous blood–brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy. Chinese Medicine. 20(1). 185–185. 1 indexed citations

Zhao, Yuyue, Guowang Cheng, Zhen Tian, et al.. (2025). Biomimetic photosynthesis nanoreactors based thylakoid synergy with metformin for reversing tumor immunosuppressive microenvironment therapy. Chemical Engineering Journal. 515. 163368–163368.

Qin, Xiaoyu, et al.. (2025). Robust Metformin Nanosystem Promotes Hair Growth in Androgenetic Alopecia. Research. 8. 780–780. 3 indexed citations

Cheng, Guowang, Zhiwen Liu, Jiaxin Wu, et al.. (2024). Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment. Journal of Controlled Release. 377. 591–605. 6 indexed citations

Liu, Wei, Guowang Cheng, Zhen Tian, et al.. (2024). Theoretical basis, state and challenges of living cell-based drug delivery systems. Theranostics. 14(13). 5152–5183. 9 indexed citations

Lan, Zhou, Weijia Liu, Guowang Cheng, et al.. (2024). Biomimetic MDSCs membrane coated black phosphorus nanosheets system for photothermal therapy/photodynamic therapy synergized chemotherapy of cancer. Journal of Nanobiotechnology. 22(1). 174–174. 20 indexed citations

Zhao, Yuyue, Zhou Lan, Guowang Cheng, et al.. (2024). Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1. Acta Biomaterialia. 180. 423–435. 6 indexed citations

Xie, Aihua, Guowang Cheng, Jiaxin Wu, et al.. (2024). Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease. Biomaterials. 312. 122749–122749. 27 indexed citations

Zhao, Yuyue, Qiong Wu, Yan You, et al.. (2023). Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy. Bioactive Materials. 33. 532–544. 19 indexed citations

10.

Cheng, Guowang, et al.. (2023). Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms. SHILAP Revista de lepidopterología. 1(3). 23 indexed citations

11.

Cheng, Guowang, et al.. (2023). [Conversion of traditional Chinese medicine (TCM) into nanomedicine:application of theory of unification of medicines and excipients].. PubMed. 48(7). 1800–1807.

12.

Cheng, Guowang, Yujing Liu, Rui Ma, et al.. (2022). Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials. Nano-Micro Letters. 14(1). 105–105. 72 indexed citations

13.

Zhao, Yuyue, Yuanwei Pan, Zhou Lan, et al.. (2022). Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy. Bioactive Materials. 19. 237–250. 99 indexed citations

14.

Cheng, Guowang, Zhongjun Li, Yujing Liu, et al.. (2022). “Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment. Journal of Controlled Release. 353. 752–766. 26 indexed citations

15.

Cheng, Guowang, Xueliang Liu, Yujing Liu, et al.. (2022). Ultrasmall Coordination Polymers for Alleviating ROS-Mediated Inflammatory and Realizing Neuroprotection against Parkinson’s Disease. Research. 2022. 9781323–9781323. 29 indexed citations

16.

Wang, Qun, Guowang Cheng, Qi Yang, et al.. (2022). Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson’s Disease. Pharmaceutics. 14(8). 1731–1731. 15 indexed citations

17.

Cui, Hao, Yan You, Guowang Cheng, et al.. (2022). Advanced materials and technologies for oral diseases. Science and Technology of Advanced Materials. 24(1). 2156257–2156257. 17 indexed citations

18.

Cheng, Guowang, Jingshan Luo, Yao Liu, et al.. (2020). Cucurbituril-Oriented Nanoplatforms in Biomedical Applications. ACS Applied Bio Materials. 3(12). 8211–8240. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact